[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340513-105":59,"doc-detail-340513-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","colorectal-cancer-screening-using-a-multi-locus-blood-based-assay-targeting-circulating-tumor-dna-methylation-a-cross-sectional-study-in-an-average-risk-population","Colorectal cancer screening using a multi-locus blood-based assay targeting circulating tumor DNA methylation - a cross-sectional study in an average-risk population","","Effective screening for colorectal cancer (CRC) supports earlier diagnosis and intervention to improve survival. This cross-sectional study prospectively assessed a community-based blood screening program in Hanjiang District, Yangzhou City, using the ColonAiQ multi-locus DNA methylation assay. Among 105,285 average-risk participants (2021–2022), ColonAiQ positivity, colonoscopy participation, lesion detection, and PPVs for CRC and advanced adenoma were quantified and associated factors analyzed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/colorectal-cancer-screening-using-a-multi-locus-blood-based-assay-targeting-circulating-tumor-dna-methylation-a-cross-sectional-study-in-an-average-risk-population/340513/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/colorectal-cancer-screening-using-a-multi-locus-blood-based-assay-targeting-circulating-tumor-dna-methylation-a-cross-sectional-study-in-an-average-risk-population/340513.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What screening method was evaluated in this study?","Question",{"text":112,"@type":113},"The study evaluated ColonAiQ, a blood-based multi-locus DNA methylation assay targeting circulating tumor DNA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was screening performance measured?",{"text":117,"@type":113},"Screening performance included ColonAiQ positivity rate, colonoscopy participation rate, lesion detection rate, and positive predictive values (PPVs) for CRC and advanced adenoma.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about ColonAiQ in average-risk participants?",{"text":121,"@type":113},"ColonAiQ effectively identified a higher-risk population, with PPVs reported for CRC and advanced adenoma and higher ColonAiQ scores among CRC cases versus healthy individuals.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340513,1790141676,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Wang et al. BMC Medicine (2024) 22:560 [https://doi.org/10.1186/s12916-024-03777-2](https://doi.org/10.1186/s12916-024-03777-2)  \nBMC Medicine  \n RESEARCH Open Access  \nColorectal cancer screening using a multi-locus blood-based assay targeting circulating tumor DNA methylation: a cross-sectional study in an average-risk population  \nBaohua Wang1†, Yunzhi Zhang2,3†, Jun Liu4†, Bin Deng5†, Qing Li6†, Hongmei Liu2†, Yi Sui2, Ning Wang1, Qin Xiao7, Wei Liu8, Yan Chen8, Yongsheng Li2, Haipeng Jia2, Qilong Yuan2, Cuiping Wang2, Wenjun Pan2, Fan Li2, Huimin Yang2, Yongfeng Wang9, Yanbing Ding5, Daoliang Xu4, Rui Liu2*, Jing-Yuan Fang9* and Jing Wu1*  \nAbstract  \nBackground Effective screening for colorectal cancer (CRC) enables earlier diagnosis and intervention to improve patient survival.  \nMethods In this study, we prospectively conducted a blood-based CRC screening program for community residents in Hanjiang District, Yangzhou City, and evaluated the screening efficacy of a blood-based multi-locus DNA methylation assay (ColonAiQ) . The ColonAiQ-positive rate and colonoscopy participation rate of the population, detection rate of intestinal lesions, and positive predictive value (PPV) of CRC and advanced adenoma (AA) were calculated, and the associated factors were explored.  \nResults A total of 105,285 participants were enrolled from January 2021 to December 2022, all of whom completed the ColonAiQ assay, yielding a positive rate of 6 .42%(6759/105,285) . The colonoscopy compliance rate was 48. 56%(3282/6759) . Intestinal lesions were detected in 1773 individuals (54 . 02%), including 63 cases of CRCs (predominately early-stage), 1195 adenomas (441 cases of AAs), 327 polyps, and 188 other benign lesions. CRC patients exhibited higher ColonAiQ scores and more positive loci compared to healthy individuals. The PPVs were 1. 92% for CRC and 13.44% for AA. Among participants, 66,121 (62 . 8%) completed questionnaires graded by the Asia–Pacific Colorectal Screening score, with 12,139 (18 . 36%) classified in the high-risk tier. High-risk participants had a higher  \n†Baohua Wang, Yunzhi Zhang, Jun Liu, Bin Deng, Qing Li and Hongmei Liu contributed equally on this work.  \n*Correspondence:  \nRui Liu [rliu@singleragenomics.com](rliu@singleragenomics.com)[ ](rliu@singleragenomics.com)Jing-Yuan Fang [jingyuanfang@sjtu.edu.cn](jingyuanfang@sjtu.edu.cn)[ ](jingyuanfang@sjtu.edu.cn)Jing Wu  \nwujing@ncncd.chinacdc.cn  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. BMC Medicine (2024) 22:560 Page 2 of 13  \nColonAiQ-positive rate (11 . 07%) and PPVs for CRC (3 .46%) and AA (22 . 18%) . Factors associated with increased detection rates for CRC and AA included male gender, older age, a history of alcohol consumption, and prior polyps. Conclusions Our study demonstrated that Col","cbCaiszdTQoM4SWS","https://ap.wps.com/l/cbCaiszdTQoM4SWS","pdf",1668305,13,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Trial registration\n# Keywords\n# Background (epidemiology and rationale)\n# Screening context and limitations","[{\"question\":\"What screening method was evaluated in this study?\",\"answer\":\"The study evaluated ColonAiQ, a blood-based multi-locus DNA methylation assay targeting circulating tumor DNA.\"},{\"question\":\"How was screening performance measured?\",\"answer\":\"Screening performance included ColonAiQ positivity rate, colonoscopy participation rate, lesion detection rate, and positive predictive values (PPVs) for CRC and advanced adenoma.\"},{\"question\":\"What did the results show about ColonAiQ in average-risk participants?\",\"answer\":\"ColonAiQ effectively identified a higher-risk population, with PPVs reported for CRC and advanced adenoma and higher ColonAiQ scores among CRC cases versus healthy individuals.\"}]","Colorectal cancer screening using a multi-locus blood-based assay targeting circulating tumor DNA methylation - a cross-sectional study in an average-risk population | PDF",1790036983,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e81cce6fcc58b24b8b1f8abb9e97ed61.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73cc118a821faf2dd105dd75a733cb4e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50ea6bdf14f683b6a71d8f32e040571b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81952f8fd07fa3c15b01d0d7c6b69a86.webp",980,1301]